JP2012509351A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012509351A5 JP2012509351A5 JP2011537657A JP2011537657A JP2012509351A5 JP 2012509351 A5 JP2012509351 A5 JP 2012509351A5 JP 2011537657 A JP2011537657 A JP 2011537657A JP 2011537657 A JP2011537657 A JP 2011537657A JP 2012509351 A5 JP2012509351 A5 JP 2012509351A5
- Authority
- JP
- Japan
- Prior art keywords
- silver
- item
- organic compound
- compound
- substituent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims description 106
- 150000002894 organic compounds Chemical class 0.000 claims description 70
- -1 silver tetrafluoroborate Chemical compound 0.000 claims description 42
- 150000001875 compounds Chemical class 0.000 claims description 34
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 26
- 229910052709 silver Inorganic materials 0.000 claims description 26
- 239000004332 silver Substances 0.000 claims description 26
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical group [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 claims description 18
- 239000012025 fluorinating agent Substances 0.000 claims description 18
- KXCAEQNNTZANTK-UHFFFAOYSA-N stannane Chemical compound [SnH4] KXCAEQNNTZANTK-UHFFFAOYSA-N 0.000 claims description 18
- 229910000080 stannane Inorganic materials 0.000 claims description 18
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 claims description 16
- 125000003118 aryl group Chemical group 0.000 claims description 10
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical class [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 claims description 9
- QRUBYZBWAOOHSV-UHFFFAOYSA-M silver trifluoromethanesulfonate Chemical compound [Ag+].[O-]S(=O)(=O)C(F)(F)F QRUBYZBWAOOHSV-UHFFFAOYSA-M 0.000 claims description 7
- 125000001072 heteroaryl group Chemical group 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 6
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 5
- JFZMMCYRTJBQQI-UHFFFAOYSA-M 1-fluoropyridin-1-ium;trifluoromethanesulfonate Chemical compound F[N+]1=CC=CC=C1.[O-]S(=O)(=O)C(F)(F)F JFZMMCYRTJBQQI-UHFFFAOYSA-M 0.000 claims description 4
- 230000015572 biosynthetic process Effects 0.000 claims description 4
- 229910052796 boron Inorganic materials 0.000 claims description 4
- 230000003197 catalytic effect Effects 0.000 claims description 4
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 claims description 4
- 239000012363 selectfluor Substances 0.000 claims description 3
- ZXSQEZNORDWBGZ-UHFFFAOYSA-N 1,3-dihydropyrrolo[2,3-b]pyridin-2-one Chemical compound C1=CN=C2NC(=O)CC2=C1 ZXSQEZNORDWBGZ-UHFFFAOYSA-N 0.000 claims description 2
- PRIGFEJKMMRJSF-UHFFFAOYSA-M 1-fluoro-2,4,6-trimethylpyridin-1-ium;trifluoromethanesulfonate Chemical compound [O-]S(=O)(=O)C(F)(F)F.CC1=CC(C)=[N+](F)C(C)=C1 PRIGFEJKMMRJSF-UHFFFAOYSA-M 0.000 claims description 2
- KDFRVNARKRKXQQ-UHFFFAOYSA-M 2,6-dichloro-1-fluoropyridin-1-ium;trifluoromethanesulfonate Chemical compound [O-]S(=O)(=O)C(F)(F)F.F[N+]1=C(Cl)C=CC=C1Cl KDFRVNARKRKXQQ-UHFFFAOYSA-M 0.000 claims description 2
- RBWNDBNSJFCLBZ-UHFFFAOYSA-N 7-methyl-5,6,7,8-tetrahydro-3h-[1]benzothiolo[2,3-d]pyrimidine-4-thione Chemical compound N1=CNC(=S)C2=C1SC1=C2CCC(C)C1 RBWNDBNSJFCLBZ-UHFFFAOYSA-N 0.000 claims description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 125000001931 aliphatic group Chemical group 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 150000001768 cations Chemical class 0.000 claims description 2
- PBJTXVTVKNXWHU-UHFFFAOYSA-N dioxidoboranyloxy(fluoro)borinate 1-fluoropyridin-1-ium pyridine Chemical compound C1=CC=NC=C1.[O-]B([O-])OB([O-])F.[O-]B([O-])OB([O-])F.[O-]B([O-])OB([O-])F.[O-]B([O-])OB([O-])F.[O-]B([O-])OB([O-])F.[O-]B([O-])OB([O-])F.[O-]B([O-])OB([O-])F.F[N+]1=CC=CC=C1.F[N+]1=CC=CC=C1.F[N+]1=CC=CC=C1.F[N+]1=CC=CC=C1.F[N+]1=CC=CC=C1.F[N+]1=CC=CC=C1.F[N+]1=CC=CC=C1.F[N+]1=CC=CC=C1.F[N+]1=CC=CC=C1.F[N+]1=CC=CC=C1.F[N+]1=CC=CC=C1.F[N+]1=CC=CC=C1.F[N+]1=CC=CC=C1.F[N+]1=CC=CC=C1.F[N+]1=CC=CC=C1.F[N+]1=CC=CC=C1.F[N+]1=CC=CC=C1.F[N+]1=CC=CC=C1.F[N+]1=CC=CC=C1.F[N+]1=CC=CC=C1.F[N+]1=CC=CC=C1 PBJTXVTVKNXWHU-UHFFFAOYSA-N 0.000 claims description 2
- 125000005842 heteroatom Chemical group 0.000 claims description 2
- 239000013067 intermediate product Substances 0.000 claims description 2
- 229910052751 metal Inorganic materials 0.000 claims description 2
- 239000002184 metal Substances 0.000 claims description 2
- 229910052757 nitrogen Inorganic materials 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 2
- CQLFBEKRDQMJLZ-UHFFFAOYSA-M silver acetate Chemical compound [Ag+].CC([O-])=O CQLFBEKRDQMJLZ-UHFFFAOYSA-M 0.000 claims description 2
- 229940071536 silver acetate Drugs 0.000 claims description 2
- LKZMBDSASOBTPN-UHFFFAOYSA-L silver carbonate Substances [Ag].[O-]C([O-])=O LKZMBDSASOBTPN-UHFFFAOYSA-L 0.000 claims description 2
- 229910001958 silver carbonate Inorganic materials 0.000 claims description 2
- 229910001961 silver nitrate Inorganic materials 0.000 claims description 2
- KKKDGYXNGYJJRX-UHFFFAOYSA-M silver nitrite Chemical compound [Ag+].[O-]N=O KKKDGYXNGYJJRX-UHFFFAOYSA-M 0.000 claims description 2
- 229910001494 silver tetrafluoroborate Inorganic materials 0.000 claims description 2
- CLDWGXZGFUNWKB-UHFFFAOYSA-M silver;benzoate Chemical compound [Ag+].[O-]C(=O)C1=CC=CC=C1 CLDWGXZGFUNWKB-UHFFFAOYSA-M 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- XGPOMXSYOKFBHS-UHFFFAOYSA-M sodium;trifluoromethanesulfonate Chemical group [Na+].[O-]S(=O)(=O)C(F)(F)F XGPOMXSYOKFBHS-UHFFFAOYSA-M 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 125000003107 substituted aryl group Chemical group 0.000 claims description 2
- 229910052717 sulfur Inorganic materials 0.000 claims description 2
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 claims 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 1
- 229910052698 phosphorus Inorganic materials 0.000 claims 1
- 239000011574 phosphorus Substances 0.000 claims 1
- LFAGQMCIGQNPJG-UHFFFAOYSA-N silver cyanide Chemical compound [Ag+].N#[C-] LFAGQMCIGQNPJG-UHFFFAOYSA-N 0.000 claims 1
- 229910001923 silver oxide Inorganic materials 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 description 18
- 239000003153 chemical reaction reagent Substances 0.000 description 14
- 239000003937 drug carrier Substances 0.000 description 10
- 239000008194 pharmaceutical composition Substances 0.000 description 10
- 239000002243 precursor Substances 0.000 description 10
- 125000001153 fluoro group Chemical group F* 0.000 description 9
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 6
- WRQKGGQCQJIVGY-UHFFFAOYSA-N Maculosin Natural products C1=C2C(OCC(O)C(C)(O)C)=C(C=CO3)C3=NC2=CC2=C1OCO2 WRQKGGQCQJIVGY-UHFFFAOYSA-N 0.000 description 6
- MHUWZNTUIIFHAS-CLFAGFIQSA-N dioleoyl phosphatidic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC MHUWZNTUIIFHAS-CLFAGFIQSA-N 0.000 description 6
- OLNTVTPDXPETLC-XPWALMASSA-N ezetimibe Chemical compound N1([C@@H]([C@H](C1=O)CC[C@H](O)C=1C=CC(F)=CC=1)C=1C=CC(O)=CC=1)C1=CC=C(F)C=C1 OLNTVTPDXPETLC-XPWALMASSA-N 0.000 description 6
- 229960000815 ezetimibe Drugs 0.000 description 6
- 239000008101 lactose Substances 0.000 description 6
- 229960004502 levodopa Drugs 0.000 description 6
- LSGOTAXPWMCUCK-RYUDHWBXSA-N maculosin Chemical compound C1=CC(O)=CC=C1C[C@H]1C(=O)N2CCC[C@H]2C(=O)N1 LSGOTAXPWMCUCK-RYUDHWBXSA-N 0.000 description 6
- 108010015341 maculosin Proteins 0.000 description 6
- 239000002446 δ-tocopherol Substances 0.000 description 6
- 239000002904 solvent Substances 0.000 description 5
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 4
- BTVYFIMKUHNOBZ-ODRIEIDWSA-N Rifamycin S Chemical class O=C1C(C(O)=C2C)=C3C(=O)C=C1NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]1(C)OC2=C3C1=O BTVYFIMKUHNOBZ-ODRIEIDWSA-N 0.000 description 4
- 150000002367 halogens Chemical group 0.000 description 4
- 125000001424 substituent group Chemical group 0.000 description 4
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 3
- RFDPVHCUOLBALB-UHFFFAOYSA-N 2-(4-fluorophenyl)-2,3-dihydrochromen-4-one Chemical compound C1=CC(F)=CC=C1C1OC2=CC=CC=C2C(=O)C1 RFDPVHCUOLBALB-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZONYXWQDUYMKFB-UHFFFAOYSA-N SJ000286395 Natural products O1C2=CC=CC=C2C(=O)CC1C1=CC=CC=C1 ZONYXWQDUYMKFB-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229930003949 flavanone Natural products 0.000 description 3
- 150000002208 flavanones Chemical class 0.000 description 3
- 235000011981 flavanones Nutrition 0.000 description 3
- DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical group CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- KLWPJMFMVPTNCC-UHFFFAOYSA-N Camptothecin Natural products CCC1(O)C(=O)OCC2=C1C=C3C4Nc5ccccc5C=C4CN3C2=O KLWPJMFMVPTNCC-UHFFFAOYSA-N 0.000 description 2
- 235000001258 Cinchona calisaya Nutrition 0.000 description 2
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- VSJKWCGYPAHWDS-FQEVSTJZSA-N camptothecin Chemical compound C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-FQEVSTJZSA-N 0.000 description 2
- 229940127093 camptothecin Drugs 0.000 description 2
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 2
- 239000002872 contrast media Substances 0.000 description 2
- VSJKWCGYPAHWDS-UHFFFAOYSA-N dl-camptothecin Natural products C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)C5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-UHFFFAOYSA-N 0.000 description 2
- 229960003399 estrone Drugs 0.000 description 2
- 238000003682 fluorination reaction Methods 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 229960000948 quinine Drugs 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- VFWRGKJLLYDFBY-UHFFFAOYSA-N silver;hydrate Chemical compound O.[Ag].[Ag] VFWRGKJLLYDFBY-UHFFFAOYSA-N 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- XWKFPIODWVPXLX-UHFFFAOYSA-N 2-methyl-5-methylpyridine Natural products CC1=CC=C(C)N=C1 XWKFPIODWVPXLX-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 150000001204 N-oxides Chemical class 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-O diazynium Chemical group [NH+]#N IJGRMHOSHXDMSA-UHFFFAOYSA-O 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 238000007040 multi-step synthesis reaction Methods 0.000 description 1
- 150000007530 organic bases Chemical group 0.000 description 1
- 239000003880 polar aprotic solvent Substances 0.000 description 1
- 238000012746 preparative thin layer chromatography Methods 0.000 description 1
- 239000003586 protic polar solvent Substances 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229940096017 silver fluoride Drugs 0.000 description 1
- REYHXKZHIMGNSE-UHFFFAOYSA-M silver monofluoride Chemical group [F-].[Ag+] REYHXKZHIMGNSE-UHFFFAOYSA-M 0.000 description 1
- FJOLTQXXWSRAIX-UHFFFAOYSA-K silver phosphate Chemical compound [Ag+].[Ag+].[Ag+].[O-]P([O-])([O-])=O FJOLTQXXWSRAIX-UHFFFAOYSA-K 0.000 description 1
- 229910000161 silver phosphate Inorganic materials 0.000 description 1
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 1
- PIILXFBHQILWPS-UHFFFAOYSA-N tributyltin Chemical group CCCC[Sn](CCCC)CCCC PIILXFBHQILWPS-UHFFFAOYSA-N 0.000 description 1
- QQQSFSZALRVCSZ-UHFFFAOYSA-N triethoxysilane Chemical compound CCO[SiH](OCC)OCC QQQSFSZALRVCSZ-UHFFFAOYSA-N 0.000 description 1
- 125000002827 triflate group Chemical group FC(S(=O)(=O)O*)(F)F 0.000 description 1
- DAHWFTWPSFSFMS-UHFFFAOYSA-N trihydroxysilane Chemical group O[SiH](O)O DAHWFTWPSFSFMS-UHFFFAOYSA-N 0.000 description 1
- YUYCVXFAYWRXLS-UHFFFAOYSA-N trimethoxysilane Chemical compound CO[SiH](OC)OC YUYCVXFAYWRXLS-UHFFFAOYSA-N 0.000 description 1
- LYRCQNDYYRPFMF-UHFFFAOYSA-N trimethyltin Chemical group C[Sn](C)C LYRCQNDYYRPFMF-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11634508P | 2008-11-20 | 2008-11-20 | |
| US61/116,345 | 2008-11-20 | ||
| US14344109P | 2009-01-09 | 2009-01-09 | |
| US61/143,441 | 2009-01-09 | ||
| US16701809P | 2009-04-06 | 2009-04-06 | |
| US61/167,018 | 2009-04-06 | ||
| US17790709P | 2009-05-13 | 2009-05-13 | |
| US61/177,907 | 2009-05-13 | ||
| PCT/US2009/065339 WO2010059943A2 (en) | 2008-11-20 | 2009-11-20 | Fluorination of organic compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012509351A JP2012509351A (ja) | 2012-04-19 |
| JP2012509351A5 true JP2012509351A5 (OSRAM) | 2013-01-17 |
Family
ID=42198823
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011537657A Pending JP2012509351A (ja) | 2008-11-20 | 2009-11-20 | 有機化合物のフッ素化 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US9024093B2 (OSRAM) |
| EP (1) | EP2376408A4 (OSRAM) |
| JP (1) | JP2012509351A (OSRAM) |
| KR (1) | KR20110095898A (OSRAM) |
| CN (1) | CN102272077A (OSRAM) |
| AU (1) | AU2009316478A1 (OSRAM) |
| CA (1) | CA2742869A1 (OSRAM) |
| WO (1) | WO2010059943A2 (OSRAM) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2303897A4 (en) * | 2008-06-05 | 2012-02-22 | Harvard College | HIGH VALENCIA PALLADIUM FLUORIDE COMPLEXES AND USES THEREOF |
| WO2010059943A2 (en) | 2008-11-20 | 2010-05-27 | President And Fellows Of Harvard College | Fluorination of organic compounds |
| GB201117019D0 (en) | 2011-10-04 | 2011-11-16 | Syngenta Ltd | Herbicidal compounds |
| WO2012054782A2 (en) * | 2010-10-20 | 2012-04-26 | Presidents And Fellows Of Harvard College | Fluoroalkoxylation of organic compounds |
| CN103596931B (zh) | 2011-04-12 | 2016-10-12 | 哈佛大学校长及研究员协会 | 有机化合物的氟化 |
| US20120309796A1 (en) | 2011-06-06 | 2012-12-06 | Fariborz Firooznia | Benzocycloheptene acetic acids |
| CN102675329B (zh) * | 2012-06-05 | 2014-12-24 | 浙江大学 | 一种正电子发射断层显像剂及其制备方法 |
| CN102675015B (zh) * | 2012-06-11 | 2014-11-05 | 中国科学院上海有机化学研究所 | 羧酸脱羧氟代的方法 |
| WO2014052622A1 (en) | 2012-09-26 | 2014-04-03 | President And Fellows Of Harvard College | Nickel fluorinating complexes and uses thereof |
| WO2014107379A1 (en) * | 2013-01-01 | 2014-07-10 | The Regents Of The University Of California | Fluorination of aryl compounds |
| US10759764B2 (en) | 2013-10-18 | 2020-09-01 | President And Fellows Of Harvard College | Fluorination of organic compounds |
| EP2891657A1 (en) | 2014-01-07 | 2015-07-08 | Centre National de la Recherche Scientifique (CNRS) | Ionic liquid supported organotin reagents for the manufacturing of radiopharmaceuticals compounds |
| US11005108B2 (en) | 2015-08-14 | 2021-05-11 | Massachusetts Institute Of Technology | Molecularly tunable heterogeneous catalysts by edge functionalization of graphitic carbons |
| CN105646119B (zh) * | 2016-01-29 | 2018-03-13 | 中南大学 | 一种肉桂酸及其衍生物脱羧上氟的方法 |
| JP2019534266A (ja) | 2016-10-14 | 2019-11-28 | 江蘇恒瑞医薬股▲ふん▼有限公司 | ５員ヘテロアリール環の架橋した環誘導体、その製造方法およびその医学的使用 |
| DK3634975T3 (da) | 2017-06-08 | 2024-05-27 | Organon R&D Finland Ltd | 17-oximer af 15.beta.-[3-propanamido]-substituerede estra-1,3,5(10)-trien-17-oner til anvendelse i inhibition af 17.beta.-hydroxysteroid-dehydrogenaser |
| EP3438077A1 (en) * | 2017-07-31 | 2019-02-06 | Studiengesellschaft Kohle mbH | Process for deoxyfluorination of phenols |
| CN108863834B (zh) * | 2018-08-13 | 2020-12-15 | 信阳师范学院 | 一种2-氟代-1,3-二羰基化合物的合成新方法 |
| CA3122049C (en) | 2018-12-05 | 2023-10-17 | Forendo Pharma Ltd | Estra-1,3,5(10)-triene compounds condensed in position 16(17) with a pyrazole ring as inhibitors of 17-hsd1 |
| WO2022029598A1 (en) * | 2020-08-04 | 2022-02-10 | University Of South Africa | Modified ezetimibe drug for cancer treatment |
| CN112710757B (zh) * | 2020-12-23 | 2022-05-17 | 九江天赐高新材料有限公司 | N-苯基双(三氟甲磺酰亚胺)的检测方法 |
| CN114716910B (zh) * | 2022-03-30 | 2022-12-27 | 浙江鑫钰新材料有限公司 | 一种合成革用有机硅耐刮擦防污涂层及其制备方法 |
| CN114805017B (zh) * | 2022-04-29 | 2023-10-10 | 上海毕得医药科技股份有限公司 | 一种2-氟-1,5-己二烯类化合物的制备方法 |
| WO2024186987A1 (en) * | 2023-03-07 | 2024-09-12 | The Board Of Trustees Of The University Of Illinois | Boron-substituted indazoles for the prevention and treatment of multiple sclerosis (ms) and other demyelinating, inflammatory and neurodegenerative diseases |
| US11999755B1 (en) | 2024-01-05 | 2024-06-04 | King Faisal University | Effective anticancer drug candidate of dinuclear palladium (II) bis-dihydrozone malonyl complex |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3137701A (en) | 1962-04-19 | 1964-06-16 | Upjohn Co | Process for the preparation of 6-deoxy-6-fluoromorphines, 6-deoxy-6-fluorocodeines, and related compounds |
| GB1177525A (en) | 1967-04-13 | 1970-01-14 | Leo Ab | New Heterocyclic Aminoketones of Therapeutic Interest |
| CH540221A (de) | 1968-03-20 | 1973-08-15 | Hoffmann La Roche | Verfahren zur Herstellung von tricyclischen Verbindungen |
| GB1483343A (en) | 1973-10-22 | 1977-08-17 | Res Inst Medicine Chem | Derivatives of amitriptyline and pharmaceutical uses thereof |
| US3972936A (en) | 1974-02-01 | 1976-08-03 | Merck & Co., Inc. | 10,11-Dihydro-5-(3-amino-propyl-or-propylidene)-10,10,11,11-tetra-fluoro-5H-dibenzo[a,d]cycloheptenes and-5-ols |
| US4236008A (en) | 1978-09-19 | 1980-11-25 | E. I. Du Pont De Nemours And Company | Fluorination of precursors for fluorine analogs of hydrocodone and oxycodone |
| IT1147349B (it) | 1980-04-09 | 1986-11-19 | Acraf | 2-parentesi quadra aperta 3-parentesi quadra aperta 4-(3-cloro-4-fluorofenil)-1-piperfrazinil parentesi quadra propil parentesi quadra chiusa-1,2,4-triazolo parentesi quadra aperta 4,3 parentesi quadra chiusa piridin-3(2h)-one |
| US4487773A (en) | 1981-03-16 | 1984-12-11 | Mead Johnson & Company | 1,2,4-Triazol-3-one antidepressants |
| JPS63166159A (ja) | 1986-12-26 | 1988-07-09 | Mitsubishi Heavy Ind Ltd | 固体電解質燃料電池 |
| DE19548146C1 (de) | 1995-12-21 | 1997-11-20 | Basf Ag | Tris(pyrazolyl)boratmetallkomplex-Katalysatoren und deren Verwendung |
| ES2297882T3 (es) | 1997-03-27 | 2008-05-01 | Toray Industries, Inc. | Derivados de morfinano y usos medicos de los mismos. |
| IL129219A0 (en) | 1998-04-07 | 2000-02-17 | Mitsui Chemicals Inc | Preparation process of acetylene derivatives |
| AU5215100A (en) | 1999-08-11 | 2001-03-13 | Universite Catholique De Louvain | Methods for preparing perfluorinated (18F)-radiolabelled nitroimidazole derivatives for cellular hypoxia detection |
| GB0115929D0 (en) | 2001-06-29 | 2001-08-22 | Nycomed Amersham Plc | Solid-phase electrophilic fluorination |
| AU2002353768A1 (en) * | 2001-07-24 | 2003-03-18 | Alamx, L.L.C. | 7-alkylidene-3-substituted-3-cephem-4-carboxylates as beta-lactamase inhibitors. |
| GB0229686D0 (en) | 2002-12-20 | 2003-01-29 | Amersham Plc | Solid-phase fluorination of benzothiazoles |
| DE10300112A1 (de) | 2003-01-07 | 2004-07-15 | Bayer Ag | Fluorierungsreagenzien und Verfahren zu deren Herstellung |
| JP2007509179A (ja) * | 2003-10-21 | 2007-04-12 | メドロジックス・ディバイス・コーポレーション | 再狭窄の予防のためのガンマ−トコフェロールの治療 |
| US7022872B2 (en) | 2003-12-19 | 2006-04-04 | Molecular Technologies, Inc. | Method for making fluorine labeled L-Dopa |
| SI1696931T1 (sl) | 2003-12-22 | 2009-08-31 | Acadia Pharm Inc | Amino substituirani diaril(a,d)cikloheptenski analogi kot muskarinski agonisti in postopki za zdravljenje nevropsihiatričnih motenj |
| GB0407952D0 (en) | 2004-04-08 | 2004-05-12 | Amersham Plc | Fluoridation method |
| WO2005117872A2 (en) | 2004-06-04 | 2005-12-15 | Dynogen Pharmaceuticals, Inc. | Dual acting snri-nmda antagonists for the treatment of genitourinary disorders |
| AR051596A1 (es) | 2004-10-26 | 2007-01-24 | Irm Llc | Compuestos heterociclicos condensados nitrogenados como inhibidores de la actividad del receptor canabinoide 1; composiciones farmaceuticas que los contienen y su empleo en la preparacion de medicamentos para el tratamiento de trastornos alimentarios |
| WO2006078752A2 (en) * | 2005-01-21 | 2006-07-27 | Methylgene, Inc. | Inhibitors of dna methyltransferase |
| WO2008081477A1 (en) | 2007-01-04 | 2008-07-10 | Natco Pharma Limited | 3-aryloxy 3-substituted propanamines |
| WO2008091818A1 (en) | 2007-01-25 | 2008-07-31 | Allergan, Inc. | Substituted arylcyclopentenes as therapeutic agents |
| RU2010114018A (ru) | 2007-09-11 | 2011-10-20 | Мондобайотек Лабораториз Аг (Li) | Применение пептид тимозина бета 4 индивидуально или в сочетании с цекропином а в качестве терапевтического средства |
| US20110054175A1 (en) | 2008-01-31 | 2011-03-03 | Tobias Ritter | System for fluorinating organic compounds |
| DE102008024221A1 (de) | 2008-05-19 | 2009-11-26 | Merck Patent Gmbh | Herstellung von CF3O-Gruppen enthaltenden Verbindungen |
| EP2303897A4 (en) | 2008-06-05 | 2012-02-22 | Harvard College | HIGH VALENCIA PALLADIUM FLUORIDE COMPLEXES AND USES THEREOF |
| WO2010059943A2 (en) | 2008-11-20 | 2010-05-27 | President And Fellows Of Harvard College | Fluorination of organic compounds |
| JP2012514654A (ja) | 2009-01-09 | 2012-06-28 | プレジデント アンド フェローズ オブ ハーバード カレッジ | フッ素含有化合物およびその使用法 |
| AU2010203461A1 (en) | 2009-01-09 | 2011-07-28 | President And Fellows Of Harvard College | Fluorine containing compounds and methods of use thereof |
| WO2011006088A2 (en) | 2009-07-09 | 2011-01-13 | President And Fellows Of Harvard College | Fluorine containing compounds and methods of use thereof |
| WO2012024604A2 (en) | 2010-08-20 | 2012-02-23 | President And Fellows Of Harvard College | High-valent palladium fluoride complexes and uses thereof |
| WO2012054782A2 (en) | 2010-10-20 | 2012-04-26 | Presidents And Fellows Of Harvard College | Fluoroalkoxylation of organic compounds |
| CN103596931B (zh) | 2011-04-12 | 2016-10-12 | 哈佛大学校长及研究员协会 | 有机化合物的氟化 |
-
2009
- 2009-11-20 WO PCT/US2009/065339 patent/WO2010059943A2/en not_active Ceased
- 2009-11-20 KR KR1020117013998A patent/KR20110095898A/ko not_active Withdrawn
- 2009-11-20 CA CA2742869A patent/CA2742869A1/en not_active Abandoned
- 2009-11-20 EP EP09828291A patent/EP2376408A4/en not_active Withdrawn
- 2009-11-20 AU AU2009316478A patent/AU2009316478A1/en not_active Abandoned
- 2009-11-20 JP JP2011537657A patent/JP2012509351A/ja active Pending
- 2009-11-20 CN CN2009801533072A patent/CN102272077A/zh active Pending
- 2009-11-20 US US13/130,033 patent/US9024093B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012509351A5 (OSRAM) | ||
| JP5587204B2 (ja) | （＋）−「ナル」モルフィナン化合物を生成するためのプロセス | |
| KR20210057031A (ko) | 메틸 6-(2,4-디클로로페닐)-5-[4-[(3s)-1-(3-플루오로프로필)피롤리딘-3-일]옥시페닐]-8,9-디히드로-7h-벤조[7]아눌렌-2-카르복실레이트의 제조 방법 | |
| JP2013227349A (ja) | （＋）−オピエートの生成のためのプロセスおよび化合物 | |
| Lang et al. | Synthesis of 8-(ω-Hydroxyalkyl)-, 8-(ω-Hydroxyalk-1-enyl)-, and 8-(ω-Hydroxyalk-1-ynyl) adenines Using the tert-Butyldimethylsilyloxymethyl Group, a New and Versatile Protecting Group of Adenine | |
| JPH05271205A (ja) | ２−（テトラゾール−５−イル）−１，１’−ビフェニル誘導体、その製造法および合成中間体としての使用 | |
| JP6423936B2 (ja) | 放射ヨウ素標識された３−フルオロプロピル−ＮＯＲ−β−ＣＩＴの調製 | |
| ES2313299T3 (es) | Procedimientos para producir morfinonas 3 o protegidas y carboxilatos de morfinona dienol 3 o protegidos. | |
| JP5465584B2 (ja) | ピラジン誘導体の製造方法 | |
| WO2010098332A1 (ja) | 多環式化合物の製造法およびその中間体 | |
| US20080051580A1 (en) | Process to Prepare Camptothecin Derivatives and Novel Intermediate and Compounds Thereof | |
| WO2016014864A1 (en) | Hydroxy-(r)-2,2'-bismethylnal trexones and uses thereof | |
| JP4474861B2 (ja) | 光学活性四級アンモニウム塩、その製造法、並びにそれを用いた光学活性α−アミノ酸誘導体の製造法 | |
| WO2014121671A1 (zh) | 一种（+）-三环羟内酯制备方法 | |
| CN103408559B (zh) | 一种喜树碱及其衍生物的快速合成方法 | |
| JP2007522151A5 (OSRAM) | ||
| CN103113297B (zh) | 一种8-芳基-1-萘酰胺化合物及其制备方法 | |
| JP5901365B2 (ja) | イミダート化合物の製造方法 | |
| Ward et al. | Synthesis of C2 Symmetric 2, 2'-Bipyridyl Imidazolidinone and Oxazaborolidine Derivatives | |
| EP2257538B1 (en) | Process for the preparation of benzodiazepine derivatives | |
| JP2005518349A5 (OSRAM) | ||
| CN104774209B (zh) | 一种9-烯丙基喜树碱衍生物的合成方法 | |
| CN103172640A (zh) | 一种(r)-n-溴甲基纳曲酮的制备方法以及纳曲酮衍生物 | |
| CN119285606A (zh) | 一种6-氟烟碱的制备方法 | |
| JP2011020944A (ja) | ポジトロン放出源化合物の製造方法 |